AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection

AA Aksyuk, H Bansal, D Wilkins, AM Stanley… - Cell Reports …, 2023 - cell.com
The nasal mucosa is an important initial site of host defense against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. However, intramuscularly administered …

Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and …

MÁ Muñoz-Alía, RA Nace, B Balakrishnan, L Zhang… - Mbio, 2024 - Am Soc Microbiol
Serum titers of SARS-CoV-2-neutralizing antibodies (nAbs) correlate well with protection
from symptomatic COVID-19 but decay rapidly in the months following vaccination or …

Milk antibody response after 3rd COVID-19 vaccine and SARS-CoV-2 infection and implications for infant protection

Y Golan, M Ilala, L Li, C Gay, S Hunagund, CY Lin… - Iscience, 2023 - cell.com
Little is known about the persistence of human milk anti-SARS-CoV-2 antibodies after 2 nd
and 3 rd vaccine doses and infection following 3 rd dose. In this study, human milk, saliva …

Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants

M ** broad-spectrum vaccines and optimal vaccination strategies is crucial to
controlling the COVID-19 pandemic. Here, we generated a chimpanzee adenoviral vector …

AZD1222-induced mucosal immune responses are influenced by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection

A Aksyuk, H Bansal, D Wilkins, A Stanley… - Cell reports …, 2022 - europepmc.org
The nasal mucosa is an important initial site of host defense against SARS-CoV-2 infection.
However, intramuscularly administered vaccines typically do not achieve high antibody titers …